Daiger S P, Chakraborty R, Reed L, Fekete G, Schuler D, Berenssi G, Nasz I, Brdicka R, Kamarýt J, Pijácková A
Graduate School of Biomedical Sciences, University of Texas Health Science Center, Houston 77225-0249.
Am J Hum Genet. 1989 Aug;45(2):310-8.
DNA haplotype data from the phenylalanine hydroxylase (PAH) locus are available from a number of European populations as a result of RFLP testing for genetic counseling in families with phenylketonuria (PKU). We have analyzed data from Hungary and Czechoslovakia together with published data from five additional countries--Denmark, Switzerland, Scotland, Germany, and France--representing a broad geographic and ethnographic range. The data include 686 complete chromosomal haplotypes for eight RFLP sites assayed in 202 unrelated Caucasian families with PKU. Forty-six distinct RFLP haplotypes have been observed to date, 10 unique to PKU-bearing chromosomes, 12 unique to non-PKU chromosomes, and the remainder found in association with both types. Despite the large number of haplotypes observed (still much less than the theoretical maximum of 384), five haplotypes alone account for more than 76% of normal European chromosomes and four haplotypes alone account for more than 80% of PKU-bearing chromosomes. We evaluated the distribution of haplotypes and alleles within these populations and calculated pairwise disequilibrium values between RFLP sites and between these sites and a hypothetical PKU "locus." These are statistically significant differences between European populations in the frequencies of non-PKU chromosomal haplotypes (P = .025) and PKU chromosomal haplotypes (P much less than .001). Haplotype frequencies of the PKU and non-PKU chromosomes also differ significantly (P much less than .001. Disequilibrium values are consistent with the PAH physical map and support the molecular evidence for multiple, independent PKU mutations in Caucasians. However, the data do not support a single geographic origin for these mutations.(ABSTRACT TRUNCATED AT 250 WORDS)
由于对苯丙酮尿症(PKU)家庭进行遗传咨询时进行了限制性片段长度多态性(RFLP)检测,来自苯丙氨酸羟化酶(PAH)基因座的DNA单倍型数据可从多个欧洲人群中获得。我们分析了来自匈牙利和捷克斯洛伐克的数据,以及来自另外五个国家——丹麦、瑞士、苏格兰、德国和法国——已发表的数据,这些国家代表了广泛的地理和人种学范围。数据包括在202个不相关的患有PKU的白种人家庭中检测的8个RFLP位点的686个完整染色体单倍型。迄今为止已观察到46种不同的RFLP单倍型,其中10种是携带PKU染色体所特有的,12种是非PKU染色体所特有的,其余的则在两种类型中均有发现。尽管观察到的单倍型数量很多(仍远低于理论最大值384),但仅5种单倍型就占正常欧洲染色体的76%以上,仅4种单倍型就占携带PKU染色体的80%以上。我们评估了这些人群中单倍型和等位基因的分布,并计算了RFLP位点之间以及这些位点与一个假设的PKU“基因座”之间的成对不平衡值。欧洲人群在非PKU染色体单倍型频率(P = 0.025)和PKU染色体单倍型频率(P远小于0.001)上存在统计学显著差异。PKU和非PKU染色体的单倍型频率也有显著差异(P远小于0.001)。不平衡值与PAH物理图谱一致,并支持白种人中多个独立PKU突变的分子证据。然而,数据并不支持这些突变有单一的地理起源。(摘要截于250字)